Europe Lipid Panel Testing Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2030 |
 Marktgröße (Basisjahr) | |
 Marktgröße (Prognosejahr) | USD 4,378.47 |
 CAGR |
% |
| Wichtige Marktteilnehmer |
>Europäischer Markt für Lipidpaneltests, nach Produkten und Dienstleistungen (Geräte, Kits und Dienstleistungen), Verschreibungsmodus (verschreibungsbasierte Tests und OTC-basierte Tests), Anwendung ( Hyperlipidämie , Hypertriglyceridämie, familiäre Hypercholesterinämie, Hypolipoproteinämie, Tangier-Krankheit, Arteriosklerose und andere), Endbenutzer (Krankenhäuser, Fachkliniken und Arztpraxen, Pathologielabore, Diagnosekliniken, ambulante chirurgische Zentren, Referenzlabore, akademische und Forschungsinstitute und andere), Vertriebskanal (Direktausschreibung, Einzelhandelsapotheke, Online-Verkauf und andere) – Branchentrends und Prognose bis 2030.
Marktanalyse und Einblicke für Lipidpaneltests in Europa
Das zunehmende Bewusstsein für Lipidpaneltests in Europa hat die Nachfrage auf diesem Markt erhöht. Die steigenden Gesundheitsausgaben für bessere Gesundheitsdienste tragen ebenfalls zum Wachstum des Marktes bei. Die wichtigsten Marktteilnehmer konzentrieren sich in dieser entscheidenden Phase auf die Einführung und Zulassung verschiedener Dienste. Darüber hinaus trägt auch die zunehmende Weiterentwicklung von Prozessen und Techniken zur steigenden Nachfrage nach Lipidpaneltests bei.
Der europäische Markt für Lipidpaneltests dürfte im Prognosejahr aufgrund der Zunahme der Marktteilnehmer und der Verfügbarkeit fortschrittlicher Dienste wachsen. Darüber hinaus sind die Hersteller in Entwicklungsaktivitäten involviert, um neue Dienste sowie effiziente und genaue Lipidpaneltests auf den Markt zu bringen. Die zunehmende Entwicklung fortschrittlicher Gesundheitstechniken fördert das Marktwachstum weiter. Schwierigkeiten wie die strengen Vorschriften für die Herstellung und Vermarktung von Lipidpaneltestprodukten könnten jedoch das Wachstum des europäischen Marktes für Lipidpaneltests im Prognosezeitraum behindern.
Laut einer Analyse von Data Bridge Market Research dürfte der europäische Markt für Lipidpaneltests bis 2030 einen Wert von 4.378,47 Millionen US-Dollar erreichen und im Prognosezeitraum eine durchschnittliche jährliche Wachstumsrate (CAGR) von 6,7 % aufweisen.
|
Berichtsmetrik |
Details |
|
Prognosezeitraum |
2023 bis 2030 |
|
Basisjahr |
2022 |
|
Historische Jahre |
2021 (anpassbar auf 2015–2020) |
|
Quantitative Einheiten |
Umsatz in Millionen, Mengen in Einheiten, Preise in USD |
|
Abgedeckte Segmente |
Produkte und Dienstleistungen (Geräte, Kits und Dienstleistungen), Verschreibungsmodus (Tests auf Rezept und OTC-basierte Tests), Anwendung (Hyperlipidämie, Hypertriglyceridämie , familiäre Hypercholesterinämie, Hypolipoproteinämie, Tangier-Krankheit, Arteriosklerose und andere), Endbenutzer (Krankenhäuser, Fachkliniken und Arztpraxen, Pathologielabore, Diagnosekliniken, ambulante chirurgische Zentren, Referenzlabore, akademische und Forschungsinstitute und andere), Vertriebskanal (Direktausschreibung, Einzelhandelsapotheke, Online-Verkauf und andere) |
|
Abgedeckte Länder |
USA, Kanada, Mexiko, Deutschland, Frankreich, Großbritannien, Italien, Spanien, Niederlande, Russland, Schweiz, übriges Europa, China, Japan, Indien, Südkorea, Australien, Singapur, Thailand, Malaysia, Indonesien, Philippinen, übriger Asien-Pazifik-Raum, Brasilien, Argentinien, übriges Südamerika, Südafrika, Saudi-Arabien, Vereinigte Arabische Emirate, Ägypten, Israel und übriger Naher Osten und Afrika |
|
Abgedeckte Marktteilnehmer |
Einige große Unternehmen, die auf dem europäischen Markt für Lipidpaneltests tätig sind, sind unter anderem Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Tochtergesellschaft von Danaher) und Sekisui Diagnostics (ein Teil von SEKISUI Chemical Co. Ltd.). |
Definition des europäischen Lipidpanel-Testmarktes
Ein Lipidprofil ist ein gängiger Bluttest, den Ärzte zur Überwachung und Früherkennung von Herz-Kreislauf-Erkrankungen durchführen. Das Profil umfasst drei Cholesterinmessungen sowie eine Triglyceridmessung.
Gesundheitsdienstleister verwenden Lipidprofile, um die kardiovaskuläre Gesundheit einer Person durch Analyse des Cholesterinspiegels in ihrem Blut zu beurteilen und um bei der Diagnose anderer Gesundheitszustände zu helfen. Das Lipidprofil bewertet das Vorhandensein bestimmter Fettmoleküle, die als Lipide bezeichnet werden, im Blut. Es misst als Paneltest mehrere Substanzen, darunter mehrere cholesterinhaltige Moleküle. Das Lipidprofil bewertet das Risiko von Herz-Kreislauf-Erkrankungen wie Herzkrankheiten, Herzinfarkt und Schlaganfall bei Kindern und Erwachsenen.
Marktdynamik für Lipidpaneltests in Europa
In diesem Abschnitt geht es um das Verständnis der Markttreiber, Vorteile, Chancen, Einschränkungen und Herausforderungen. All dies wird im Folgenden ausführlich erläutert:
Treiber
- ZUNEHMENDE PRÄVALENZ CHRONISCHER KRANKHEITEN
Ein Lipidprofil ist ein gängiger Bluttest, der von Gesundheitsdienstleistern verwendet wird, um das Risiko von Herz-Kreislauf-Erkrankungen und anderen chronischen Krankheiten zu überwachen und zu untersuchen. Das Profil umfasst drei Cholesterinmessungen und eine Triglyceridmessung. Während Anbieter und medizinisches Fachpersonal Lipidprofile hauptsächlich zum Screening oder zur Überwachung des Cholesterinspiegels verwenden. Anbieter verwenden sie manchmal als Teil des Diagnoseprozesses für bestimmte Gesundheitszustände, die Ihren Lipidspiegel beeinflussen können, darunter Pankreatitis, chronische Nierenerkrankung und Hypothyreose.
Abschließend lässt sich also sagen, dass die steigende Zahl chronischer Krankheiten wie Herz-Kreislauf-Erkrankungen, chronische Nierenerkrankungen, Lebererkrankungen und verschiedene andere chronische Krankheiten zu einer erhöhten Nachfrage nach Lipidprofilen geführt hat und dass die steigende Marktnachfrage nach Lipidpanel-Testkits das Wachstum des europäischen Marktes für Lipidpanel-Tests in den kommenden Jahren vorantreiben wird.
Zurückhaltung
- HOHE KOSTEN BEIM TESTEN VON PANELS
Ein Lipidprofiltest ist ein Lipidprofil, ein Cholesterinprofil oder ein Herzrisikoprofil. Dabei handelt es sich um eine Kombination von Bluttests, die dabei helfen, den Blutfettspiegel wie Cholesterin und Triglyceride zu messen. Dieses Cholesterin und diese Triglyceride sind gute und schlechte Fettarten.
Die Testpanels verursachen enorme Kosten für den Entwicklungsprozess. Da das Konzept festgelegt werden muss, müssen die Materialien beschafft werden und es ist wichtig, die Vorlaufzeiten zu berücksichtigen. Darüber hinaus ist der Prozess zeitaufwändig, da das Gerätedesign ausreichend Zeit benötigt, um vollständig auszureifen, bevor es auf den Markt kommt.
Darüber hinaus werden alle Änderungen, die erneut überprüft werden müssen, Zeit in Anspruch nehmen. Die zunehmenden Fortschritte bei Biosensor-Testformaten und anderen ergänzenden Technologien erforderten eine effektive Investition für einen erfolgreichen Betrieb und einen Projektrisikomanagementplan. Die Einrichtung von F&E zur Durchführung von Forschung ist mit hohen Kosten verbunden und führt zu teuren Geräten. Daher stellt dieser Faktor eine große Einschränkung für den europäischen Markt für Lipidpaneltests dar.
Gelegenheit
WACHSTUM DES TECHNOLOGISCHEN FORTSCHRITTS
Ein Lipidprofil ist ein gängiger Bluttest, den Ärzte zur Überwachung und Früherkennung von Herz-Kreislauf-Erkrankungen durchführen. Das Profil umfasst drei Cholesterinmessungen sowie eine Triglyceridmessung.
Technologische Entwicklungen bei Lipidprofiltests führen zu höherer Genauigkeit, hoher Sensibilität, höherer Erfolgsrate und neueren Materialien, je nach ihrer Verwendung in verschiedenen Lipidprofiltests. Die Kommerzialisierung von Lipidprofiltestgeräten und -produkten auf Basis fortschrittlicher Technologie für Diagnose- und Testverfahren hat die Verbrauchernachfrage erhöht, was wiederum die Marktnachfrage ankurbelt.
Daher ist zu erwarten, dass der technologische Fortschritt und die Weiterentwicklung der Lipidpanel-Testmethode das Wachstum auf dem europäischen Markt für Lipidpanel-Tests vorantreiben werden.
Herausforderung
MANGEL AN QUALIFIZIERTEN UND ZERTIFIZIERTEN FACHKRÄFTEN
Der Bedarf an qualifizierten und zertifizierten Fachkräften stellt für Lipidprofiltests eine große Herausforderung dar. Die Nachfrage nach Lipidprofiltests zur Diagnose steigt aufgrund der zunehmenden Fälle von Fettleibigkeit, Herz-Kreislauf-Erkrankungen und Cholesterin in Europa. Der Mangel an qualifizierten Fachkräften in den Diagnosezentren behindert jedoch das Marktwachstum.
Die Instrumente, Methoden und Verfahren zur Diagnose von Lipidprofiltests sind fortgeschritten, es gibt jedoch gewisse Lücken in Standardisierung, Angleichung und Wissen. Techniker müssen sich mit technischen Ausbildungslücken im Zusammenhang mit Problemen auseinandersetzen und fortgeschrittene Methoden sicher anwenden, um Verfahren effizient durchzuführen. Bei Lipidprofiltests werden dringend qualifizierte Fachkräfte für die Methodenentwicklung, Validierung, Bedienung und Fehlerbehebung benötigt.
Post-COVID-19-Auswirkungsanalyse auf den europäischen Markt für Lipidpaneltests
Covid-19 hat dem Diagnostiksektor massiven Schaden zugefügt, da die Patientenzahlen seit Anfang 2020 stark zurückgegangen sind. Die Pandemie löste bei den Menschen ein unheimliches Gefühl der Angst aus, das sich schließlich auf Krankenhaus-/Klinik- und Laborbesuche auswirkte. Regelmäßige Kontrolluntersuchungen wurden umständlich, stressig und zeitaufwändig. Während der Diagnostiksektor insgesamt einen Rückgang zu erleiden schien, war der Bereich der Heimdiagnostik der Silberstreif am Horizont der neuen Entwicklung.
Jüngste Entwicklungen
- Im Oktober 2022 gab Eurofins Scientific den Beginn des größten europäischen Biomonitoringprojekts für PFAS (Polyfluoralkyl) im Blut Antwrep bekannt, das von der Agentur für Pflege und Gesundheit der flämischen Regierung in Auftrag gegeben wurde. Diese Produkteinführung hat dem Unternehmen bei der Erweiterung seines Produktportfolios geholfen.
- Im Dezember 2022 gab die Laboratory Corporation of America Holdings bekannt, dass sie den Betrieb in einem neuen, größeren Labor für anatomische Pathologie und Histologie in Los Angeles aufgenommen hat. Dieser neue Betrieb half dem Unternehmen, seine zentralen Laborkapazitäten in Europa zu erweitern.
Marktumfang für Lipidpaneltests in Europa
Der europäische Markt für Lipidpaneltests ist in fünf wichtige Segmente unterteilt: Produkte und Dienstleistungen, Verschreibungsmodus, Anwendung, Endbenutzer und Vertriebskanal. Das Wachstum zwischen den Segmenten hilft Ihnen bei der Analyse von Wachstumsnischen und Strategien zur Marktbearbeitung und zur Bestimmung Ihrer wichtigsten Anwendungsbereiche und der Unterschiede in Ihren Zielmärkten.
PRODUKTE & SERVICES
- GERÄTE
- KITS
- DIENSTLEISTUNGEN
Auf der Grundlage von Produkten und Dienstleistungen ist der europäische Markt für Lipidpaneltests in Geräte, Kits und Dienstleistungen segmentiert.
REZEPTMODUS
- VERSCHREIBUNGSBASIERTE TESTS
- OTC-BASIERTE TESTS
Auf der Grundlage der Verschreibungsart ist der europäische Markt für Lipidpaneltests in verschreibungspflichtige Tests und rezeptfreie Tests segmentiert.
ANWENDUNG
- HYPERLIPIDÄMIE
- HYPERTRIGLYCERIDÄMIE
- FAMILIENHAFTE HYPERCHOLESTERINÄMIE
- HYPO-LIPOPROTEINAMIE
- TANGIER-KRANKHEIT
- Arteriosklerose
- ANDERE
Auf der Grundlage der Anwendung ist der europäische Markt für Lipidpaneltests in Hyperlipidämie, Hypertriglyceridämie, familiäre Hypercholesterinämie, Hypolipoproteinämie, Morbus Tangier, Arteriosklerose und andere unterteilt.
Endverbraucher
- KRANKENHAUS
- FACHKLINIKEN UND ARZTPRAXEN
- PATHOLOGIE-LABORATORIEN
- DIAGNOSTIKKLINIKEN
- AMBULANTE CHIRURGISCHE ZENTREN
- REFERENZLABORATORIEN
- AKADEMISCHE UND FORSCHUNGSINSTITUTE
- ANDERE
Auf der Grundlage des Endbenutzers ist der europäische Markt für Lipidpaneltests in Krankenhäuser, Fachkliniken und Arztpraxen, Pathologielabore, Diagnosekliniken, ambulante chirurgische Zentren, Referenzlabore, akademische und Forschungsinstitute und andere unterteilt.
VERTRIEBSKANAL
- DIREKTE AUSSCHREIBUNG
- APOTHEKE IM EINZELHANDEL
- ONLINE-VERKAUF
- ANDERE
Auf der Grundlage der Vertriebskanäle ist der europäische Markt für Lipidpaneltests in Direktausschreibungen, Apothekeneinzelhandel, Online-Verkäufe und Sonstiges segmentiert.
Europa: Regionale Analyse/Einblicke zum Lipid-Panel-Test-Markt
Der europäische Markt für Lipidpaneltests ist in fünf wichtige Segmente unterteilt: Produkte und Dienstleistungen, Verschreibungsmodus, Anwendung, Endbenutzer und Vertriebskanal.
Die in diesem Marktbericht abgedeckten Länder sind Deutschland, Frankreich, Großbritannien, Italien, Spanien, die Türkei, die Niederlande, Russland, die Schweiz und das übrige Europa.
Aufgrund der steigenden Nachfrage aus den Schwellenmärkten und der Expansion dominiert das Vereinigte Königreich die Region Europa.
Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, demografische Daten des Landes, Regulierungsgesetze und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Darüber hinaus werden bei der Prognoseanalyse der Länderdaten die Präsenz und Verfügbarkeit europäischer Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.
Wettbewerbsumfeld und Analyse der Marktanteile für Lipidpaneltests in Europa
Die Wettbewerbslandschaft des europäischen Marktes für Lipidpaneltests liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktzulassungen, Produktbreite und -breite, Anwendungsdominanz, Produkttyp-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens auf den europäischen Markt für Lipidpaneltests.
Zu den großen Unternehmen auf dem europäischen Markt für Lipidpaneltests zählen unter anderem Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Tochtergesellschaft von Danaher) und Sekisui Diagnostics (ein Teil von SEKISUI Chemical Co. Ltd.).
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Inhaltsverzeichnis
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE LIPID PANEL TESTING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS & SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 PATENT ANALYSIS
5 INDUSTRIAL INSIGHTS
5.1 KEY PRICING STRATEGY
6 EUROPE LIPID PANEL TESTING MARKET, REGULATIONS
6.1 REGULATORY SCENARIO IN EUROPE
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
7.1.2 GROWING NUMBER OF CASES OF DYSLIPIDEMIA
7.1.3 RAPID CHANGES IN LIFESTYLE CHANGES LEAD TO LIPID DISORDERS
7.1.4 RISE IN PREFERENCE FOR HOMECARE TESTING IN LIPID PANEL TESTING
7.2 RESTRAINTS
7.2.1 STRICT GOVERNMENT REGULATIONS
7.2.2 HIGH COST ASSOCIATED WITH TESTING PANELS
7.3 OPPORTUNITIES
7.3.1 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
7.3.2 RISE IN THE PREVALENCE OF OBESITY AMONG PEOPLE
7.3.3 INCREASING ADOPTION OF POINT-OF-CARE LIPID PANEL TESTING
7.4 CHALLENGES
7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS
7.4.2 LACK OF STANDARDIZATION OF LIPID PANEL TESTING
8 EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES
8.1 OVERVIEW
8.2 SERVICES
8.2.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
8.2.2 TOTAL CHOLESTEROL TEST
8.2.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
8.2.4 TRIGLYCERIDES/ VLDL TEST
8.2.5 NON-HDL CHOLESTEROL TEST
8.2.6 OTHERS
8.3 KITS
8.3.1 STRIPS
8.3.1.1 THREE-ANALYTE TEST STRIPS
8.3.1.2 DUAL-ANALYTE TEST STRIPS
8.3.1.3 SINGLE-ANALYTE TEST STRIPS
8.3.2 LANCETS
8.3.3 CONTROLS
8.3.3.1 MULTI-CHEMISTRY CONTROLS
8.3.3.2 HDL CHOLESTEROL CONTROLS
8.3.3.3 OTHERS
8.3.4 CAPILLARY TUBES
8.4 DEVICES
8.4.1 BY MODALITY
8.4.1.1 STANDALONE
8.4.1.2 HANDHELD
8.4.1.3 PORTABLE
8.4.2 BY TYPE
8.4.2.1 LABORATORY BASED
8.4.2.2 POINT OF CARE BASED
9 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE
9.1 OVERVIEW
9.2 PRESCRIPTION-BASED TESTING
9.3 OTC-BASED TESTING
10 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 HYPERLIPIDEMIA
10.2.1 TOTAL CHOLESTEROL TEST
10.2.2 TRIGLYCERIDES/ VLDL TEST
10.2.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.2.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.2.5 NON-HDL CHOLESTEROL TEST
10.2.6 OTHERS
10.3 HYPERTRIGLYCERIDEMIA
10.3.1 TRIGLYCERIDES/ VLDL TEST
10.3.2 TOTAL CHOLESTEROL TEST
10.3.3 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.3.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.3.5 NON-HDL CHOLESTEROL TEST
10.3.6 OTHERS
10.4 ATHEROSCLEROSIS
10.4.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.4.2 TOTAL CHOLESTEROL TEST
10.4.3 TRIGLYCERIDES/ VLDL TEST
10.4.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.4.5 NON-HDL CHOLESTEROL TEST
10.4.6 OTHERS
10.5 FAMILIAL HYPERCHOLESTEROLEMIA
10.5.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.5.2 TOTAL CHOLESTEROL TEST
10.5.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.5.4 TRIGLYCERIDES/ VLDL TEST
10.5.5 NON-HDL CHOLESTEROL TEST
10.5.6 OTHERS
10.6 HYPO LIPOPROTEINEMIA
10.6.1 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.6.2 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.6.3 TRIGLYCERIDES/ VLDL TEST
10.6.4 TOTAL CHOLESTEROL TEST
10.6.5 NON-HDL CHOLESTEROL TEST
10.6.6 OTHERS
10.7 TANGIER DISEASE
10.7.1 HIGH DENSITY LIPOPROTEIN (HDL) TEST
10.7.2 LOW DENSITY LIPOPROTEIN (LDL) TEST
10.7.3 TOTAL CHOLESTEROL TEST
10.7.4 TRIGLYCERIDES/ VLDL TEST
10.7.5 NON-HDL CHOLESTEROL TEST
10.7.6 OTHERS
10.8 OTHERS
11 EUROPE LIPID PANEL TESTING MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.2.1 BY TYPE
11.2.1.1 PRIVATE
11.2.1.1.1 SERVICES
11.2.1.1.2 KITS
11.2.1.1.3 DEVICES
11.2.1.2 PUBLIC
11.2.1.2.1 SERVICES
11.2.1.2.2 KITS
11.2.1.2.3 DEVICES
11.2.2 BY TIER
11.2.2.1 TIER 1
11.2.2.1.1 SERVICES
11.2.2.1.2 KITS
11.2.2.1.3 DEVICES
11.2.2.2 TIER 2
11.2.2.2.1 SERVICES
11.2.2.2.2 KITS
11.2.2.2.3 DEVICES
11.2.2.3 TIER 3
11.2.2.3.1 SERVICES
11.2.2.3.2 KITS
11.2.2.3.3 DEVICES
11.3 DIAGNOSTIC CLINICS
11.3.1 SERVICES
11.3.2 KITS
11.3.3 DEVICES
11.4 SPECIALTY CLINICS & PHYSICIAN OFFICES
11.4.1 SERVICES
11.4.2 KITS
11.4.3 DEVICES
11.5 REFERENCE LABORATORIES
11.5.1 SERVICES
11.5.2 KITS
11.5.3 DEVICES
11.6 AMBULATORY SURGICAL CENTERS
11.6.1 SERVICES
11.6.2 KITS
11.6.3 DEVICES
11.7 PATHOLOGY LABORATORIES
11.7.1 SERVICES
11.7.2 KITS
11.7.3 DEVICES
11.8 ACADEMIC AND RESEARCH INSTITUTES
11.8.1 SERVICES
11.8.2 KITS
11.8.3 DEVICES
11.9 OTHERS
12 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL PHARMACY
12.3.1 HOSPITAL PHARMACIES
12.3.2 DRUG STORES
12.3.3 OTHERS
12.4 ONLINE SALES
12.5 OTHERS
13 EUROPE LIPID PANEL TESTING MARKET, BY REGION
13.1 EUROPE
13.1.1 U.K.
13.1.2 GERMANY
13.1.3 FRANCE
13.1.4 RUSSIA
13.1.5 ITALY
13.1.6 SPAIN
13.1.7 TURKEY
13.1.8 NETHERLANDS
13.1.9 SWITZERLAND
13.1.10 REST OF EUROPE
14 EUROPE LIPID PANEL TESTING MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 EUROPE LIPID PANEL TESTING MARKET, COMPANY PROFILE
16.1 QUEST DIAGNOSTICS INCORPORATED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 EUROFINS SCIENTIFIC
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 LABORATORY CORPORATION OF AMERICA HOLDINGS
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENT
16.4 F. HOFFMANN-LA ROCHE LTD.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENT
16.5 RANDOX LABORATORIES LTD.
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ABBOTT
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 COMPANY SHARE ANALYSIS
16.6.4 PRODUCT PORTFOLIO
16.6.5 RECENT DEVELOPMENT
16.7 AWARENESS TECHNOLOGY, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ARUP LABORATORIES
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BIO-RAD LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENT
16.1 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER)
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 BOSTON HEART DIAGNOSTICS CORPORATION
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 CPC DIAGNOSTICS
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 CRODA INTERNATIONAL PLC.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 DIATRON
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 EKF DIAGNOSTICS
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 EVERLYWELL, INC.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 ELITECH GROUP
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENT
16.18 HORIBA MEDICAL
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 MYLAB BOX
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 NOVA BIOMEDICAL
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 PTS DIAGNOSTICS
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 SIEMENS HEALTHCARE GMBH
16.22.1 COMPANY SNAPSHOT
16.22.2 REVENUE ANALYSIS
16.22.3 PRODUCT PORTFOLIO
16.22.4 RECENT DEVELOPMENT
16.23 SINOCARE
16.23.1 COMPANY SNAPSHOT
16.23.2 REVENUE ANALYSIS
16.23.3 PRODUCT PORTFOLIO
16.23.4 RECENT DEVELOPMENT
16.24 SD BIOSENSOR, INC.
16.24.1 COMPANY SNAPSHOT
16.24.2 REVENUE ANALYSIS
16.24.3 PRODUCT PORTFOLIO
16.24.4 RECENT DEVELOPMENT
16.25 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.)
16.25.1 COMPANY SNAPSHOT
16.25.2 REVENUE ANALYSIS
16.25.3 PRODUCT PORTFOLIO
16.25.4 RECENT DEVELOPMENTS
16.26 SPARK DIAGNOSTICS PVT. LTD.
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
16.27 THERMO FISHER SCIENTIFIC INC.
16.27.1 COMPANY SNAPSHOT
16.27.2 REVENUE ANALYSIS
16.27.3 PRODUCT PORTFOLIO
16.27.4 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Tabellenverzeichnis
TABLE 1 THE BELOW-MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID PANEL TESTING DEVICES OFFERED BY DIFFERENT MANUFACTURERS-
TABLE 2 EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 5 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 EUROPE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 EUROPE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 11 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 13 EUROPE PRESCRIPTION-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE OTC-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 16 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 20 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 24 EUROPE HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 EUROPE HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 28 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 30 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 EUROPE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 33 EUROPE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 35 EUROPE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 36 EUROPE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 EUROPE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 38 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 EUROPE SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 EUROPE SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 42 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 44 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 50 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 52 EUROPE DIRECT TENDER IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 55 EUROPE ONLINE SALES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 EUROPE LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 59 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 60 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 61 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 EUROPE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 EUROPE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 65 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 66 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 67 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 68 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 69 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 71 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 73 EUROPE HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 EUROPE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 76 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 EUROPE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 EUROPE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 80 EUROPE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 81 EUROPE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 82 EUROPE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 83 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 84 EUROPE SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 85 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 86 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 87 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 88 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 90 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 91 U.K. LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 92 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 93 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 94 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 95 U.K. KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 U.K. STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 U.K. CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 99 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 101 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 102 U.K. LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 103 U.K. LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 U.K. HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 105 U.K. HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 106 U.K. ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 107 U.K. FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 U.K. HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 109 U.K. TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 110 U.K. LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 U.K. HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 112 U.K. PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 113 U.K. PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 U.K. HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 115 U.K. TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 116 U.K. TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 117 U.K. TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 U.K. DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 119 U.K. SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 120 U.K. REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 U.K. AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 122 U.K. PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 123 U.K. ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 124 U.K. LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 125 U.K. RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 126 GERMANY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 127 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 128 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 129 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 130 GERMANY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 GERMANY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 GERMANY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 134 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 135 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 136 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 137 GERMANY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 138 GERMANY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 GERMANY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 140 GERMANY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 141 GERMANY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 142 GERMANY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 GERMANY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 144 GERMANY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 145 GERMANY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 146 GERMANY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 147 GERMANY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 GERMANY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 GERMANY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 150 GERMANY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 GERMANY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 152 GERMANY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 153 GERMANY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 154 GERMANY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 155 GERMANY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 156 GERMANY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 GERMANY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 158 GERMANY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 GERMANY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 GERMANY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 161 FRANCE LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 162 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 163 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 164 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 165 FRANCE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 166 FRANCE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 FRANCE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 168 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 169 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 170 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 171 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 172 FRANCE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 173 FRANCE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 FRANCE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 FRANCE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 FRANCE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 177 FRANCE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 178 FRANCE HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 FRANCE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 180 FRANCE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 181 FRANCE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 FRANCE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 183 FRANCE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 FRANCE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 185 FRANCE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 186 FRANCE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 187 FRANCE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 188 FRANCE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 189 FRANCE SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 190 FRANCE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 191 FRANCE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 192 FRANCE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 193 FRANCE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 194 FRANCE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 195 FRANCE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 196 RUSSIA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 197 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 198 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 199 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 200 RUSSIA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 201 RUSSIA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 202 RUSSIA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 203 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 204 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 205 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 206 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 207 RUSSIA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 208 RUSSIA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 209 RUSSIA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 210 RUSSIA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 211 RUSSIA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 212 RUSSIA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 213 RUSSIA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 214 RUSSIA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 RUSSIA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 216 RUSSIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 217 RUSSIA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 218 RUSSIA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 219 RUSSIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 220 RUSSIA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 221 RUSSIA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 222 RUSSIA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 223 RUSSIA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 224 RUSSIA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 225 RUSSIA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 226 RUSSIA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 227 RUSSIA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 228 RUSSIA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 229 RUSSIA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 230 RUSSIA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 231 ITALY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 232 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 233 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 234 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 235 ITALY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 236 ITALY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 237 ITALY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 238 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 239 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 240 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 241 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 242 ITALY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 243 ITALY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 ITALY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 ITALY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 ITALY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 ITALY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 ITALY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 ITALY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 ITALY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 251 ITALY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 252 ITALY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 253 ITALY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 254 ITALY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 255 ITALY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 256 ITALY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 ITALY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 258 ITALY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 ITALY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 260 ITALY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 ITALY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 262 ITALY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 263 ITALY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 264 ITALY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 265 ITALY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 266 SPAIN LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 267 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 268 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 269 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 270 SPAIN KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 271 SPAIN STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 272 SPAIN CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 273 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 274 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 275 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 276 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 277 SPAIN LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 278 SPAIN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 279 SPAIN HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 280 SPAIN HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 281 SPAIN ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 282 SPAIN FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 283 SPAIN HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 284 SPAIN TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 285 SPAIN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 286 SPAIN HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 SPAIN PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 288 SPAIN PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 289 SPAIN HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 290 SPAIN TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 291 SPAIN TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 292 SPAIN TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 293 SPAIN DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 294 SPAIN SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 295 SPAIN REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 296 SPAIN AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 297 SPAIN PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 298 SPAIN ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 299 SPAIN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 300 SPAIN RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 301 TURKEY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 302 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 303 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 304 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 305 TURKEY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 306 TURKEY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 307 TURKEY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 308 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 309 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 310 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 311 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 312 TURKEY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 313 TURKEY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 314 TURKEY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 315 TURKEY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 316 TURKEY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 317 TURKEY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 318 TURKEY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 319 TURKEY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 320 TURKEY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 321 TURKEY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 322 TURKEY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 323 TURKEY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 324 TURKEY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 325 TURKEY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 326 TURKEY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 327 TURKEY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 328 TURKEY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 329 TURKEY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 330 TURKEY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 331 TURKEY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 332 TURKEY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 333 TURKEY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 334 TURKEY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 335 TURKEY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 336 NETHERLANDS LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 337 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 338 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 339 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 340 NETHERLANDS KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 341 NETHERLANDS STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 342 NETHERLANDS CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 343 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 344 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 345 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 346 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 347 NETHERLANDS LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 348 NETHERLANDS LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 349 NETHERLANDS HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 350 NETHERLANDS HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 351 NETHERLANDS ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 352 NETHERLANDS FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 353 NETHERLANDS HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 NETHERLANDS TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 355 NETHERLANDS LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 356 NETHERLANDS HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 357 NETHERLANDS PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 358 NETHERLANDS PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 359 NETHERLANDS HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 360 NETHERLANDS TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 361 NETHERLANDS TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 362 NETHERLANDS TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 363 NETHERLANDS DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 364 NETHERLANDS SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 365 NETHERLANDS REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 366 NETHERLANDS AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 367 NETHERLANDS PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 368 NETHERLANDS ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 369 NETHERLANDS LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 370 NETHERLANDS RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 371 SWITZERLAND LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
TABLE 372 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 373 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)
TABLE 374 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)
TABLE 375 SWITZERLAND KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 376 SWITZERLAND STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 377 SWITZERLAND CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 378 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 379 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 380 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP
TABLE 381 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 382 SWITZERLAND LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)
TABLE 383 SWITZERLAND LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 384 SWITZERLAND HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 385 SWITZERLAND HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 386 SWITZERLAND ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 387 SWITZERLAND FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 388 SWITZERLAND HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 389 SWITZERLAND TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 390 SWITZERLAND LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 391 SWITZERLAND HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 392 SWITZERLAND PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 393 SWITZERLAND PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 394 SWITZERLAND HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)
TABLE 395 SWITZERLAND TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 396 SWITZERLAND TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 397 SWITZERLAND TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 398 SWITZERLAND DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 399 SWITZERLAND SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 400 SWITZERLAND REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 401 SWITZERLAND AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 402 SWITZERLAND PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 403 SWITZERLAND ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 404 SWITZERLAND LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 405 SWITZERLAND RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 406 REST OF EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)
Abbildungsverzeichnis
FIGURE 1 EUROPE LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 2 EUROPE LIPID PANEL TESTING MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE LIPID PANEL TESTING MARKET: DROC ANALYSIS
FIGURE 4 EUROPE LIPID PANEL TESTING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE LIPID PANEL TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE LIPID PANEL TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE LIPID PANEL TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE LIPID PANEL TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 EUROPE LIPID PANEL TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE LIPID PANEL TESTING MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE EUROPE LIPID PANEL TESTING MARKET IN THE FORECAST PERIOD
FIGURE 12 THE PRODUCTS & SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE LIPID PANEL TESTING MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE LIPID PANEL TESTING MARKET
FIGURE 14 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2022
FIGURE 15 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, CAGR (2023-2030)
FIGURE 17 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, LIFELINE CURVE
FIGURE 18 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2022
FIGURE 19 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, CAGR (2023-2030)
FIGURE 21 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, LIFELINE CURVE
FIGURE 22 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, 2022
FIGURE 23 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE LIPID PANEL TESTING MARKET: BY END USER, 2022
FIGURE 27 EUROPE LIPID PANEL TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE LIPID PANEL TESTING MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE LIPID PANEL TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE LIPID PANEL TESTING MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2022)
FIGURE 36 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 EUROPE LIPID PANEL TESTING MARKET: PRODUCTS & SERVICES (2023-2030)
FIGURE 39 EUROPE LIPID PANEL TESTING MARKET: COMPANY SHARE 2022 (%)
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
